Pamela Tenaerts, MD

Pamela Tenaerts, MD is Chief Scientific Officer at Medable, Inc. Dr. Tenaerts leads efforts to drive responsible adoption of decentralized research methodologies with evidence-based metrics and best practices. Dr. Tenaerts joined Medable from Duke University, where she led the Clinical Trials Transformation Initiative’s (Public Private Partnership co-founded by Duke University and the Food and Drug Administration) efforts to develop and drive adoption of practices that increase the quality and efficiency of clinical trials. She is a member of the Drug Forum at the National Academies of Science, a Dime Founding Members Council member and a Board Member of the MedStar Research Institute

Tenaerts is one of the leading advocates for innovation in clinical trials, with an emphasis on protocol design and QbD, patient engagement, responsible evidence generation and clinical trial methodology improvements. With more than 30 years’ experience in the conduct of clinical trials across a number of stakeholders, she practiced medicine in both the emergency department and as a family practitioner in the private practice setting before embarking on a career in research.